Overview Financials News + Filings Key Docs Ownership Insiders
|
Bellevue Life Sciences Acquisition Corp.
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 |
| Source | Source |
Turnover Ratios |
Asset turnover | 0.1 | |
|
Returns on Capital |
ROIC (excluding intangibles) | 4.9% | |
ROIC (including intangibles) | 3.4% | 0.8% |
ROE | -94.3% | -156.0% |
ROA | 2.9% | 0.5% |
|
Cash Conversion Cycle |
Days sales outstanding | 0.0 | 0.0 |
|